Repaglinide Impurity 12 | CAS 332347-69-0 - Request Quote
Repaglinide Impurity 12
| SZ CAT No: | SZ-R032021 |
| CAS No | 332347-69-0 |
| Mol.F. | C15H20O5 |
| Mol.Wt. | 280.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Repaglinide Impurity 12 is chemically Ethyl 2-ethoxy-4-(2-ethoxy-2-oxoethyl)benzoate. Repaglinide Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Repaglinide Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Repaglinide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 332347-69-0
Purchase 332347-69-0
Order 332347-69-0
Enquire 332347-69-0
price of 332347-69-0
332347-69-0 Supplier
332347-69-0 Manufacturer
332347-69-0 Exporter
buy high quality Repaglinide Impurity 12
Purchase Repaglinide Impurity 12
Repaglinide Impurity 12 suppliers
Repaglinide Impurity 12 manufacturers
Repaglinide Impurity 12 price
Order Repaglinide Impurity 12
Enquire Repaglinide Impurity 12
Repaglinide Impurity 12 cost
Repaglinide Impurity 12 Supplier
Repaglinide Impurity 12 Distributor
Repaglinide Impurity 12 for Method Validation
Repaglinide Reference Standard
Repaglinide Impurity 12 for ANDA Filing
Repaglinide Impurity 12 for Forced Degradation Studies
Repaglinide Impurity 12 Identification Standards
Repaglinide Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


